imatinib mesylate has been researched along with Cardiac Tamponade in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Carroll, SJ; Dayton, JD; Donovan, DJ; Holzer, RJ; Siskind, T; Thanjan, MT | 1 |
Battezzi, A; Bernardinetti, M; Bove, T; Parisella, L; Tomasino, S; Vetrugno, L | 1 |
Barton, JC; Jones, SC; Lamberth, WC; Reymann, MT; Scott, VC | 1 |
3 other study(ies) available for imatinib mesylate and Cardiac Tamponade
Article | Year |
---|---|
Chylous pericardial effusion with cardiac tamponade in a child treated with imatinib.
Topics: Cardiac Surgical Procedures; Cardiac Tamponade; Child; Female; Humans; Imatinib Mesylate; Pericardial Effusion; Respiration Disorders | 2023 |
Cardiac tamponade and graft versus host disease: one more reason to remember.
Topics: Biomarkers; Cardiac Tamponade; Echocardiography; Graft vs Host Disease; Heart Function Tests; Hematopoietic Stem Cell Transplantation; Hemodynamics; Humans; Imatinib Mesylate; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardiocentesis; Treatment Outcome | 2018 |
Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia.
Topics: Benzamides; Cardiac Tamponade; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pericardial Effusion; Piperazines; Pyrimidines; Radiography; Weight Gain | 2002 |